Tag: Jon Bigelow

CHC_general1

07/11/2022

FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions

CDER.News

05/23/2022

Only 6 Percent of Novel Drug Approvals in 2021 Involved Advisory Committee Meetings

CHC_Legislative1

05/17/2022

User Fee Legislation Markup Suggests Added FDA Regulatory Authorities

CHC-offLabel2

05/09/2022

Clinical Trials Not Sufficiently Diverse – and Diversity Data Often Not Reported

HHSOIGNews

05/02/2022

Medicare Advantage Plans May Promise More but Deliver Less

CHC_general1

04/25/2022

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

CHC_general2

04/12/2022

CMS Sticks to Plan: No Aduhelm Coverage Unless in Clinical Trial

CHC_washingtonfocus2

04/04/2022

Biden’s 2023 Budget: Big Increases for FDA, CDC, Pandemic Preparedness

CHC_Legislative1

03/21/2022

House Shines Spotlight on Accelerated Approvals, May Tie Legislation to PDUFA